1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Analyze analyst forecasts for the company and compare them with competitors.
1.38B
Better than TLRY's estimated revenue of 960.37M.
-538.81M
Worse than TLRY's estimated ebitda of -375.91M.
-0.10
Worse than TLRY's estimated eps of -0.09.
-72.64M
Worse than TLRY's estimated net income of -64.86M.
-663.51M
Worse than TLRY's estimated ebit of -462.90M.
455.84M
Worse than TLRY's estimated sg&a expense of 318.02M.
View analysts' price targets and recommendations, and compare them with competitors.
No Data
No price target data available for this metric.
Hold
Equal to TLRY's analyst recommendation of Hold.
Analyze DCF forecasts for the company and compare them with competitors.
2.81B
Revenue has increased from the previous period.
19.82%
Revenue growth rate is unchanged from the previous period.
-1.10B
EBITDA has decreased from the previous period.
-39.14%
EBITDA margin is unchanged from the previous period.
-1.35B
EBIT has decreased from the previous period.
-48.20%
EBIT margin is unchanged from the previous period.
371.26M
Depreciation has increased from the previous period.
2.01B
Total cash has increased from the previous period.
71.52%
Cash percentage is unchanged from the previous period.
415.31M
Receivables have increased from the previous period.
14.78%
Receivables percentage is unchanged from the previous period.
1.13B
Inventories have increased from the previous period.
40.34%
Inventory percentage is unchanged from the previous period.
322.34M
Accounts payable has increased from the previous period.
11.47%
Payables percentage is unchanged from the previous period.
-249.80M
Capital expenditure has increased from the previous period.
-8.89%
CapEx percentage is unchanged from the previous period.
14.21%
WACC is unchanged from the previous period.
14.92%
Cost of equity is unchanged from the previous period.
12.72%
Cost of debt is unchanged from the previous period.
2.19
Beta is unchanged from the previous period.
742.65M
Diluted shares outstanding is unchanged from the previous period.
558.58M
Total debt is unchanged from the previous period.
1.30B
Total equity is unchanged from the previous period.
1.86B
Total capital is unchanged from the previous period.
30.06%
Debt weighting is unchanged from the previous period.
69.94%
Equity weighting is unchanged from the previous period.
-1.34B
EBIAT has decreased from the previous period.
-1.42B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-11.86B
Terminal value is unchanged from the previous period.
-9.55B
Enterprise value is unchanged from the previous period.
229.28M
Net debt is unchanged from the previous period.
-9.78B
Equity value is unchanged from the previous period.
-13.17
Equity value per share is unchanged from the previous period.
